Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Historic Debt to Equity for Anaptysbio (ANAB) over the last 4 years, with Q4 2018 value amounting to $0.0.

  • Anaptysbio's Debt to Equity fell 9476.69% to $0.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $0.0, marking a year-over-year decrease of 9476.69%. This contributed to the annual value of $0.0 for FY2018, which is 9476.69% down from last year.
  • As of Q4 2018, Anaptysbio's Debt to Equity stood at $0.0, which was down 9476.69% from $0.0 recorded in Q3 2018.
  • In the past 5 years, Anaptysbio's Debt to Equity registered a high of $0.12 during Q1 2017, and its lowest value of -$0.36 during Q4 2016.
  • For the 4-year period, Anaptysbio's Debt to Equity averaged around -$0.01, with its median value being $0.02 (2018).
  • Its Debt to Equity has fluctuated over the past 5 years, first crashed by 15904.49% in 2016, then soared by 10680.15% in 2017.
  • Anaptysbio's Debt to Equity (Quarter) stood at -$0.14 in 2015, then crashed by 159.04% to -$0.36 in 2016, then skyrocketed by 106.8% to $0.02 in 2017, then crashed by 94.77% to $0.0 in 2018.
  • Its last three reported values are $0.0 in Q4 2018, $0.0 for Q3 2018, and $0.01 during Q2 2018.